Conjugated Estrogens
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00286 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | migraine disorder | KG + DL |
| 2 | migraine with brainstem aura | KG + DL |
| 3 | antithrombin deficiency type 2 | KG + DL |
| 4 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 5 | rheumatoid arthritis | KG + DL |
| 6 | heparin cofactor 2 deficiency | KG + DL |
| 7 | Prinzmetal angina | KG + DL |
| 8 | hemoglobinopathy | KG + DL |
| 9 | migraine with or without aura, susceptibility to | KG + DL |
| 10 | thrombophilia | KG + DL |
| 11 | brachydactyly-syndactyly syndrome | KG + DL |
| 12 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 13 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 14 | beta-thalassemia with other manifestations | KG + DL |
| 15 | homozygous familial hypercholesterolemia | KG + DL |
| 16 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 17 | atrophoderma vermiculata | KG + DL |
| 18 | pyropoikilocytosis, hereditary | KG + DL |
| 19 | hyperthyroidism | KG + DL |
| 20 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 21 | ulerythema ophryogenesis | KG + DL |
| 22 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 23 | myocardial infarction (disease) | KG + DL |
| 24 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 25 | pyruvate kinase deficiency of red cells | KG + DL |
| 26 | myocardial infarction | KG + DL |
| 27 | diabetic nephropathy | KG + DL |
| 28 | tendinitis | KG + DL |
| 29 | fibromyalgia | KG + DL |
| 30 | coronary thrombosis | KG + DL |
| 31 | idiopathic granulomatous myositis | KG + DL |
| 32 | myositis fibrosa | KG + DL |
| 33 | amenorrhea (disease) | KG + DL |
| 34 | hyperthyroxinemia | KG + DL |
| 35 | exostosis | KG + DL |
| 36 | septal myocardial infarction | KG + DL |
| 37 | peripheral arterial disease | KG + DL |
| 38 | peripheral vascular disease | KG + DL |
| 39 | posteroinferior myocardial infarction | KG + DL |
| 40 | posterolateral myocardial infarction | KG + DL |
| 41 | methemoglobinemia, alpha type | KG + DL |
| 42 | conjunctivitis | KG + DL |
| 43 | coronary stenosis | KG + DL |
| 44 | inclusion body myositis | KG + DL |
| 45 | methemoglobin reductase deficiency | KG + DL |
| 46 | hypoalphalipoproteinemia | KG + DL |
| 47 | gout | KG + DL |
| 48 | thrombotic disease | KG + DL |
| 49 | non-inflammatory vasculopathy | KG + DL |
| 50 | conjunctivitis (disease) | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.